Today's most important initiations

Stifel initiated coverage on Pliant Therapeutics (NASDAQ: PLRX) with a Buy rating and a price target of $33.00, noting that Bexotegrast has the potential to achieve a differentiated profile within the large and competitive Idiopathic Pulmonary Fibrosis (IPF) market.

Piper Sandler assumed coverage on Block Inc. (NYSE: SQ) with an Overweight rating and a price target of $93.00. The analysts expect the company to increase customer engagement through Square and Cash App, which they believe will generate outsized revenue and operating income growth relative to peers. Shares gained more than 7% today.

JPMorgan initiated coverage on Mobileye N.V (NASDAQ: MBLY) with an Overweight rating and a price target of $50.00. According to the analysts, the company is well positioned to deliver a secure revenue and earnings ramp on account of a ramp in ADAS revenue, driven by both higher ADAS adoption as well as higher content per vehicle, and a high likelihood capability in relation to Autonomous driving ramping closer to the end of the decade.

Credit Suisse assumed coverage on Credicorp (NYSE: BAP) with an Outperform rating and a price target of $142.00.

By Davit Kirakosyan

Want this type of news in real-time as it happens? Upgrade to StreetInsider.com Premium Here

You May Also Be Interested In

• Hertz cuts guidance, announces notes and stock offerings, shares sink
• Ecolab pops as Citi sees improving setup into Q2 earnings
• Stay long AI-capex winners into the peak, Stifel says despite bubble fears